Ian S. Zagon

11.4k total citations
291 papers, 9.6k citations indexed

About

Ian S. Zagon is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Ian S. Zagon has authored 291 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Cellular and Molecular Neuroscience, 92 papers in Molecular Biology and 56 papers in Physiology. Recurrent topics in Ian S. Zagon's work include Neuropeptides and Animal Physiology (137 papers), Cancer, Stress, Anesthesia, and Immune Response (54 papers) and Neuroendocrine Tumor Research Advances (38 papers). Ian S. Zagon is often cited by papers focused on Neuropeptides and Animal Physiology (137 papers), Cancer, Stress, Anesthesia, and Immune Response (54 papers) and Neuroendocrine Tumor Research Advances (38 papers). Ian S. Zagon collaborates with scholars based in United States, India and Czechia. Ian S. Zagon's co-authors include Patricia J. McLaughlin, Steven R. Goodman, Joseph W. Sassani, Jill P. Smith, Renee N. Donahue, Michael F. Verderame, Robert S. Lasher, Cheng Fan, B.M. Riederer and Yan Wu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Ian S. Zagon

289 papers receiving 9.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian S. Zagon United States	51	4.8k	3.5k	1.9k	1.6k	1.1k	291	9.6k
Patricia J. McLaughlin United States	48	4.0k 0.8×	2.5k 0.7×	1.8k 0.9×	773 0.5×	956 0.8×	243	7.3k
Roy O. Weller United Kingdom	64	5.3k 1.1×	3.4k 1.0×	1.3k 0.7×	4.5k 2.8×	848 0.7×	213	16.1k
Douglas E. Brenneman United States	54	5.4k 1.1×	4.3k 1.2×	506 0.3×	1.6k 1.0×	794 0.7×	192	9.9k
Henry G. Friesen Canada	73	2.2k 0.4×	5.4k 1.5×	642 0.3×	1.5k 0.9×	1.1k 1.0×	351	18.7k
Kristopher T. Kahle United States	54	3.9k 0.8×	5.5k 1.6×	732 0.4×	674 0.4×	513 0.4×	222	11.2k
Uwe‐Karsten Hanisch Germany	46	3.3k 0.7×	4.1k 1.2×	502 0.3×	2.5k 1.6×	715 0.6×	98	15.7k
David Pleasure United States	63	3.8k 0.8×	4.5k 1.3×	314 0.2×	1.1k 0.7×	646 0.6×	272	11.4k
Volker Höllt Germany	61	6.0k 1.2×	5.2k 1.5×	577 0.3×	1.8k 1.2×	888 0.8×	183	10.3k
Robert Nitsch Germany	61	3.8k 0.8×	5.4k 1.5×	404 0.2×	1.4k 0.9×	616 0.5×	176	13.1k
William Rostène France	56	5.2k 1.1×	4.2k 1.2×	362 0.2×	1.2k 0.8×	1.3k 1.1×	267	10.8k

Countries citing papers authored by Ian S. Zagon

Since Specialization

Citations

This map shows the geographic impact of Ian S. Zagon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian S. Zagon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian S. Zagon more than expected).

Fields of papers citing papers by Ian S. Zagon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian S. Zagon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian S. Zagon. The network helps show where Ian S. Zagon may publish in the future.

Co-authorship network of co-authors of Ian S. Zagon

This figure shows the co-authorship network connecting the top 25 collaborators of Ian S. Zagon. A scholar is included among the top collaborators of Ian S. Zagon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian S. Zagon. Ian S. Zagon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Díaz, David René Rodríguez, et al.. (2024). Topical naltrexone increases aquaporin 5 production in the lacrimal gland and restores tear production in diabetic rats. Experimental Biology and Medicine. 249. 10175–10175. 3 indexed citations

McLaughlin, Patricia J., et al.. (2021). Naltrexone blockade of OGFr enhances cutaneous wound closure in diabetic rats. SHILAP Revista de lepidopterología. 11. 100098–100098.

Zagon, Ian S., et al.. (2021). β-endorphin and opioid growth factor as biomarkers of physical ability in multiple sclerosis. Multiple Sclerosis and Related Disorders. 50. 102868–102868. 2 indexed citations

McLaughlin, Patricia J., et al.. (2017). Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds. Advances in Wound Care. 6(9). 279–288. 28 indexed citations

Liang, David, Joseph W. Sassani, Patricia J. McLaughlin, & Ian S. Zagon. (2016). Topical Application of Naltrexone to the Ocular Surface of Healthy Volunteers: A Tolerability Study. Journal of Ocular Pharmacology and Therapeutics. 32(2). 127–132. 12 indexed citations

Zagon, Ian S., et al.. (2014). Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds. Advances in Wound Care. 3(6). 419–427. 16 indexed citations

Zagon, Ian S.. (2014). Opioid growth factor and the treatment of human pancreatic cancer: A review. World Journal of Gastroenterology. 20(9). 2218–2218. 29 indexed citations

Zagon, Ian S., et al.. (2012). Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis. Brain Research Bulletin. 90. 43–51. 26 indexed citations

Fan, Cheng, Patricia J. McLaughlin, William A. Banks, & Ian S. Zagon. (2009). Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 297(3). R844–R852. 17 indexed citations

10.

Sassani, Joseph W., et al.. (2007). Topically Applied Naltrexone Restores Corneal Reepithelialization in Diabetic Rats. Journal of Ocular Pharmacology and Therapeutics. 23(2). 89–102. 43 indexed citations

11.

Smith, Jill P., et al.. (2007). Low-Dose Naltrexone Therapy Improves Active Crohn's Disease. The American Journal of Gastroenterology. 102(4). 820–828. 97 indexed citations

12.

Zagon, Ian S., et al.. (2006). Corneal Safety of Topically Applied Naltrexone. Journal of Ocular Pharmacology and Therapeutics. 22(5). 377–387. 23 indexed citations

13.

Zagon, Ian S., et al.. (1999). Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met5]enkephalin1The nucleotide sequence of the rat OGFr has been deposited in GenBank under accession number AF 156878.1. Brain Research. 849(1-2). 147–154. 35 indexed citations

14.

Smith, Jill P. & Ian S. Zagon. (1994). Cholecystokinin receptors and human pancreatic adenocarcinoma. International Journal of Pancreatology. 16. 243–246. 4 indexed citations

15.

Zagon, Ian S. & Patricia J. McLaughlin. (1993). Growth factors and hormones. Chapman & Hall eBooks. 13 indexed citations

16.

Zagon, Ian S. & P. J. McLaughlin. (1990). Endogenous opioids, opioids receptors, and cancer. 3(2). 101–103. 1 indexed citations

17.

Goodman, Steven R. & Ian S. Zagon. (1987). Brain spectrin: Structure, location, and function. A symposium overview. Brain Research Bulletin. 18(6). 773–776. 2 indexed citations

18.

Zagon, Ian S. & Patricia J. McLaughlin. (1984). Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: A role for endogenous opioid systems in cancer. Life Sciences. 35(4). 409–416. 67 indexed citations

19.

Zagon, Ian S. & Patricia J. McLaughlin. (1981). Naloxone prolongs the survival time of neuroblastoma-bearing mice. Proceedings of the American Association for Cancer Research. 22. 1 indexed citations

20.

Zagon, Ian S. & Patricia J. McLaughlin. (1980). Neurobehavioral development in rats following transplacental exposure to ethylnitrosourea. 2(4). 297–305. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact